Dr. Saurabh Chaturvedi
Assistant Professor
School of Allied Health Sciences & Management (SAHSM)
Google ScholarScopus ProfileEducational Qualifications
PhD
Experience
Academic / Teaching Experience
2 .5 Years
Area of Specialization / Research
Immune mediated inflammation, Drug efflux pumps.
Notable Publications
- 1.
Ravi Mishra, Zia Hashim, Mansi Gupta, Rachna Chaturvedi, Harshit Singh, Alok Nath, Durga Prasanna Misra, Ajmal Khan, Mohit Kumar Rai, Shivani Srivastava, Saurabh Chaturvedi , Vikas Agarwal. Histone Deacetylase-2 inducer like Theophylline has a potential to improve Glucorticoid responsiveness in severe uncontrolled asthma by reducing P-glycoprotein-1/MPR-1. Indian Journal of Rheumatology. 2022; 17(1): 47-56, IF: NA.
2022 - 2.
Gaurav Pande, Harshit Singh, Saurabh Chaturvedi , Manjunath Hatti, Alok Kumar, Ravi Mishra, Prabhakar Mishra, Krishna VP, Arun Bhadauria, Samir Mohindra, Durga Prasanna Misra, Vivek Saraswat, Vikas Agarwal. “Utility of Neutrophil CD64 in distinguishing bacterial infection from inflammation in severe alcoholic hepatitis fulfilling SIRS criteria”. Scientific Reports, October 2021;11(19726), IF: 5.13. (doi: https://doi.org/10.1038/s41598-021-99276-y).
2021 - 3.
Narayan Prasad, Harshit Singh, Akhilesh Jaiswal, Saurabh Chaturvedi , Vikas Agarwal. “Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistance phenotype in childhood idiopathic nephrotic syndrome”. The Pharmacogenomics Journal, October 2021; 21(5):566-573, IF: 3.67 .
2021 - 4.
Saurabh Chaturvedi, Mohit Kumar Rai, Harshit Singh, Durga Prasanna Misra, Narayan Prasad, Vinita Agrawal, Vikas Agarwal. “Dual inhibition by Phosphodiesterase-5 and 5-HT 2B inhibitor lead to near complete amelioration of fibrotic potential of human adult dermal fibroblasts isolated from scleroderma patient”. Indian Journal of Rheumatology , March 2021; 16(1):43-48. IF: NA . (doi: 10.4103/injr.injr_169_19).
2021 - 5.
Avinash Jain, Harshit Singh, Alok Nath, Saurabh Chaturvedi , Sajal Ajmani, Durga P Misra, Vikas Agarwal. “Distinct T Cell immunophenotypic signature in a subset sarcoidosis patients with arthritis”. Journal of the Royal College of Physicians of Edinburgh . 2020 September; 50:226-32. IF: 0.78 .
2020 - 6.
Sunil Pradhan, Animesh Das, Harshit Singh, Saurabh Chaturvedi, Kritika Singh, Ravi Mishra, Durga Prasanna Misra, Vikas Agarwal . “ Steroid Responsiveness in Duchenne Muscular Dystrophy- Predictive Value of Epigenetic Regulator Histone Deacetylase 2”. Indian Journal of Pediatrics , 2020 Sep; 87(9): 692-698. doi: 10.1007/s12098-020-03183-5. IF: 5.32.
2020 - 7.
Harshit Singh, Vikas Agarwal, Saurabh Chaturvedi , Durga Prasanna Misra, Akhilesh Kumar Jaiswal, Narayan Prasad. “Reciprocal Relationship between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome”. Frontiers in Pharmacology . 2019 May 22; 10:558. doi: 10.3389/fphar.2019.00558. eCollection 2019. PMID: 31191307. IF: 5.99.
2019 - 8.
Saurabh Chaturvedi, Durga Prasanna Misra, Narayan Prasad, Kailash Rastogi, Harshit Singh, Mohit Kumar Rai, Vikas Agarwal. “ 5‐HT 2 and 5‐HT 2B antagonists attenuate pro‐fibrotic phenotype in human adult dermal fibroblasts by blocking TGF‐β1‐induced non‐canonical signaling pathways including STAT3: implications for fibrotic diseases like scleroderma”. International Journal of Rheumatic Diseases . 2018 Dec: 21(12): 2128-2138. doi: 10.1111/1756-185X.13386. Epub 2018 Sep 12. PMID: IF: 2.45.
2018 - 9.
Sajal Ajmani, Harshit Singh, Saurabh Chaturvedi , Ravi Mishra, Mohit Kumar Rai, Avinash Jain, Durga Prasanna Misra, Vikas Agarwal. “Utility of Neutrophil CD64 and Serum TREM-1 in Distinguishing Bacterial Infection from Disease Flare in SLE and ANCA-associated Vasculitis”. Clinical Rheumatology . 2018 Nov; 38(4): 997-1005. doi: 10.1007/s10067-018-4334-5. Epub 2018 Nov 16. PMID: 30446886. IF: 3.65.
2018 - 10.
Pralay Shakar Ghosh, Harshit Singh, Afzal Azim, Vikas Agarwal, Saurabh Chaturvedi , Sai Saran, Prabhaker Mishra, Mohan Gurjar, Arvind Kumar Baronia, Banani Poddar, Ratender Kumar Singh, Ravi Mishra. “Correlation of Neutrophil CD64 With Clinical Profile and Outcome of Sepsis Patients During Intensive Care Unit Stay”. Indian Journal of Critical Care Medicine . 2018 Aug; 22(8):569-574. PMID: 30186006. IF: NA.
2018 - 11.
Narayan Prasad, Akhilesh Jaiswal, Vikas Agarwal, Shashi Kumar, Saurabh Chaturvedi , Subhash Yadav, Amit Gupta, Raj Kumar Sharma, Dharmendra Bhadauria and Anupama Kaul. “FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study”. Clinical Kidney Journal. 2016 Oct; 9(5): 669-76. doi: 10.1093/ckj/sfw065. PMID: 27679713. IF: 5.86.
2016 - 12.
Narayan Prasad, Akhilesh Kumar Jaiswal, Vikas Agarwal, Brijesh Yadav, Raj Kumar Sharma, Mohit Rai, Harshit Singh, Saurabh Chaturvedi , Ajay Singh. “Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: A longitudinal study”. Cytokine . 2015 Apr; 72(2):190-196. doi: 10.1016/j.cyto.2014.12.028. PMID:25661194. IF: 3.93.
2015 - 13.
Minakshi Rana, Sukka Santosh Reddy, Preeti Maurya, Vishal Singh, Saurabh Chaturvedi , Kamalpreet Kaur, Heena Agarwal, Hafsa Ahmad, Arshi Naqvi, Anil Kumar Dwivedi, Madhu Dikshit, Manoj Kumar Barthwal. “Turmerone enriched standardized Curcuma longa extract alleviates LPS induced inflammation and cytokine production by regulating TLR4–IRAK1–ROS–MAPK–NFκB axis”. Journal of Functional Foods. 2015 June; 16: 152–163. doi: 10.1016/j.jff.2015.04.034. IF: 5.23.
2015
Awards & Achievements
Awarded Senior Research Fellowship by Indian Council of Medical Research, New Delhi, India for a period of three years (...
2016
Awarded Senior Research Fellowship by Indian Council of Medical Research, New Delhi, India for a period of three years (2016- 2019) at Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, UP, India.
Qualified ‘Graduate Pharmacy Aptitude Test (GPAT)-2011’ with All India Rank 1171 conducted by All India Council of Techn...
2011
Qualified ‘Graduate Pharmacy Aptitude Test (GPAT)-2011’ with All India Rank 1171 conducted by All India Council of Technical Education, New Delhi, India and organized by The Maharaja Sayajirao University of Baroda, Vadodara.
Awarded GPAT-2011 fellowship by All India Council of Technical Education, New Delhi, India for a period of two years dur...
2011
Awarded GPAT-2011 fellowship by All India Council of Technical Education, New Delhi, India for a period of two years during Master’s degree (2011-2013) at Manipal College of Pharmaceutical Sciences, Manipal, India.
Awarded ‘First in Pharmaceutical Chemistry’ subjects of B. Pharm course examinations held during academic years 2007-08 ...
2007
Awarded ‘First in Pharmaceutical Chemistry’ subjects of B. Pharm course examinations held during academic years 2007-08 to 2010-11.
Awarded with honorarium (300$) for oral presentation at 42 nd Annual meeting of The Korean Society of Nephrology – Hybri...
2022
Awarded with honorarium (300$) for oral presentation at 42 nd Annual meeting of The Korean Society of Nephrology – Hybrid Meeting, 26 th – 29th May, 2022, Seoul, South Korea.
Awarded with honorarium (300$) for oral presentation at 41 st Annual meeting of The Korean Society of Nephrology -Fully ...
2021
Awarded with honorarium (300$) for oral presentation at 41 st Annual meeting of The Korean Society of Nephrology -Fully Virtual Meeting, 2nd – 5 th September, 2021, Seoul, South Korea.
Awarded with honorarium (300$) for oral presentation at 40th Annual meeting of The Korean Society of Nephrology -Fully V...
2020
Awarded with honorarium (300$) for oral presentation at 40th Annual meeting of The Korean Society of Nephrology -Fully Virtual Meeting, 25th – 27th September, 2020, Seoul, South Korea.
Andrew Douglas College Journal Award (Sarcoid and other granulomatous conditions category) for the year 2020 by the AD a...
2020
Andrew Douglas College Journal Award (Sarcoid and other granulomatous conditions category) for the year 2020 by the AD award committee for the paper titled “ Distinct T Cell immunophenotypic signature in a subset of sarcoidosis patients with arthritis”.
Best Poster presentation award at “49th Indian Society of Nephrology (ISNCON)” as a delegate for poster presentation, he...
2018
Best Poster presentation award at “49th Indian Society of Nephrology (ISNCON)” as a delegate for poster presentation, held in Bhubaneshwar, India, during 20th – 23rd December, 2018.
Best Oral presentation award at “48th Indian Society of Nephrology (ISNCON)” as a delegate for oral presentation, held i...
2017
Best Oral presentation award at “48th Indian Society of Nephrology (ISNCON)” as a delegate for oral presentation, held in New Delhi, India, during 14th -17th December, 2017.
Best paper award titled “P -glycoprotein and Multidrug resistance associated protein 1 on different T cell subsets in id...
2017
Best paper award titled “P -glycoprotein and Multidrug resistance associated protein 1 on different T cell subsets in idiopathic Nephrotic syndrome in children” at “54th European Renal Association- European Dialysis and Transplant Association (ERA-EDTA), as a delegate for oral presentation, held in Madrid, Spain, 3rd to 6th June, 2017.
Awarded with Early Career Research Travel Award to attend and present a poster as a delegate “ 19th World Congress of Ba...
2023
Awarded with Early Career Research Travel Award to attend and present a poster as a delegate “ 19th World Congress of Basic & Clinical Pharmacology (WCP2023)” to be held in Glasgow, Scotland, during 2 nd -7 th July, 2023.
Attended and awarded with travel grant “16th Indian Society of Nephrology North Zone (ISNNZ) 2020” as a delegate for pos...
2020
Attended and awarded with travel grant “16th Indian Society of Nephrology North Zone (ISNNZ) 2020” as a delegate for poster presentation, held in Lucknow, India, during 28th February -1 st March, 2020.
Attended and awarded with American Association of Immunology (AAI) travel grant “17th International Congress of Immunolo...
2019
Attended and awarded with American Association of Immunology (AAI) travel grant “17th International Congress of Immunology” as a delegate for oral presentation, held in Beijing, China, during 19th -23rd October, 2019.
Attended and awarded with ISN World Congress of Nephrology (WCN) travel grant as a delegate for poster presentation, hel...
2019
Attended and awarded with ISN World Congress of Nephrology (WCN) travel grant as a delegate for poster presentation, held in Melbourne, Australia, during 12th -15th April, 2019.
Attended and awarded with travel grant “49th Indian Society of Nephrology (ISNCON)” as a delegate for poster presentatio...
2018
Attended and awarded with travel grant “49th Indian Society of Nephrology (ISNCON)” as a delegate for poster presentation, held in Bhubneshwar, India, during 20th -23rd December, 2018.
Attended “34th Annual Conference of Indian Rheumatology Association (IRACON) as a delegate for oral presentation held in...
2018
Attended “34th Annual Conference of Indian Rheumatology Association (IRACON) as a delegate for oral presentation held in Guwahati, India, during 6th – 9 th December, 2018.
Attended and awarded with travel grant “18th World Congress of Pharmacology (WCP)” as a delegate for poster presentation...
2018
Attended and awarded with travel grant “18th World Congress of Pharmacology (WCP)” as a delegate for poster presentation, held in Kyoto, Japan, during 1st -8 th July, 2018.
Attended “33rd Annual Conference of Indian Rheumatology Association (IRACON) as a delegate for oral presentation held in...
2017
Attended “33rd Annual Conference of Indian Rheumatology Association (IRACON) as a delegate for oral presentation held in Lucknow, India, during 30th November–3 rd December, 2017.
Attended and awarded with travel grant “48th Indian Society of Nephrology (ISNCON)” as a delegate for oral presentation,...
2017
Attended and awarded with travel grant “48th Indian Society of Nephrology (ISNCON)” as a delegate for oral presentation, held in New Delhi, India, during 14th -17th December, 2017.
Attended and awarded with travel grant “43rd Indian Immunology Society (IMMUNOCON)” as a delegate for oral presentation,...
2017
Attended and awarded with travel grant “43rd Indian Immunology Society (IMMUNOCON)” as a delegate for oral presentation, held in Vishakapatnam, India, during 16th -18th February, 2017. 10. Attended and awarded with travel grant “47th Indian Society of Nephrology (ISNCON)” as a delegate for poster presentation, held in Mumbai, India, during 15th -18th December 2016.
Title of Invention: A Method to Determine a Steroid-Resistant Phenotype in Childhood Idiopathic Nephrotic Syndrome by Ut...
Title of Invention: A Method to Determine a Steroid-Resistant Phenotype in Childhood Idiopathic Nephrotic Syndrome by Utilizing a Pharmacogenomic Biomarkers.
Name of Inventors: Narayan Prasad, Vikas Agarwal, Akhilesh Kumar Jaiswal, Saurabh Chaturvedi and Harshit Singh
Patent Number: 2021105595
Status: Awarded
Awarding Agency: Commonwealth of Australia, Australian Government, IP Australia
Award Date: 16-08-2021
2021
Book Chapters
- 1.
Does Present Day Treatment of Ankylosing Spondylitis Help in Stoppage of Progression of Disease? — Medicine Update, Volume 33
Jaypee Brothers Medical Publishers2023
Paper / Poster Presentations
- 1.
Substrates, Cell lines, Biochips (HEP2, 2010, Primate Liver) at Immunofluorescence Microscopy in Autoantibody diagnostics. 37 th Annual Conference of Indian Rheumatology Association, 23 rd -27 th Novemebr, 2022, Indore, Madhya Pradesh, India (Presenter).
2010 - 2.
5-HT 2 /5-HT 2B receptor antagonism mitigates fibrotic potential of peritoneal fibroblasts by targeting STAT3 pathways in PD patients. International Society for Peritoneal Dialysis (ISPD) Congress, 11 th -14 th August 2022, Singapore (Presenter).
2022 - 3.
Synergy of selective inhibitor of PDE-5 and 5-HT 2B receptor: A potent anti-fibrotic strategy for abrogating fibrotic potential of peritoneal fibroblasts in PD patients. 42 nd Annual meeting of The Korean Society of Nephrology, 26 th -29 th May 2022, Seoul, South Korea (Presenter).
2022 - 4.
Phosphodiesterase-5 inhibitor/SB204741 in combination almost completely abrogate fibrotic potential of human peritoneal fibroblasts isolated from CAPD patients. 41 st Annual meeting of The Korean Society of Nephrology, 2 nd -5 th September 2021, Seoul, South Korea (Presenter).
2021 - 5.
Phosphodiesterase-5/5-HT 2B inhibitors in combination almost completely abrogate fibrotic potential of human peritoneal fibroblasts isolated from CAPD patients. 40 th Annual meeting of The Korean Society of Nephrology, 25 th -27 th September 2020, Seoul, South Korea (Presenter).
2020 - 6.
5-HT 2 /5-HT 2B receptor antagonism attenuate fibrotic phenotype of peritoneal fibroblasts via non-canonical signalling pathways in CAPD patients. 16 th Indian Society of Nephrology North Zone (ISNNZ), 28 th February -1 st March 2020, Lucknow, Uttar Pradesh, India (Presenter).
2020 - 7.
5-HT 2 and 5-HT 2B receptor antagonism abrogate fibrotic phenotype of peritoneal fibroblasts by targeting STAT3 pathway in patients receiving continuous ambulatory peritoneal dialysis. 17 th International Congress of Immunology (IUIS), 19 th -23 rd October 2019, Beijing, China (Presenter).
2019 - 8.
5-HT 2 and 5-HT 2B receptor inhibition attenuate peritoneal fibrosis by targeting non-canonical signalling pathways including STAT3. ISN World Congress of Nephrology (WCN), 12 th -15 th April 2019, Melbourne, Australia.
2019 - 9.
5-HT 2 and 5-HT 2B receptor inhibition attenuate peritoneal fibrosis by blocking non-canonical signalling pathways including STAT3. 49 th Annual Conference of Indian Society of Nephrology (ISNCON), 20 th -23 rd December 2018, Bhubneshwar, Orissa, India (Presenter).
2018 - 10.
Dual inhibition by Phosphodiesterase-5 and 5-HT 2B inhibitors lead to near complete amelioration of fibrotic potential of human dermal fibroblasts isolated from scleroderma patients. 34 th Annual Conference of Indian Rheumatology Association (IRACON), 6 th – 9 th December 2018, Guwahati, Assam, India (Presenter).
2018 - 11.
5-HT2 and 5-HT2B inhibitors mitigate fibrotic phenotype of peritoneal fibroblasts via non-canonical signaling in patients on continuous ambulatory peritoneal dialysis. 18 th World Congress of Pharmacology (WCP), 1 st -8 th July 2018, Kyoto, Japan (Presenter).
2018 - 12.
5-HT2 and 5-HT2B Antagonism Attenuate Non-Canonical Signaling in Fibrotic Phenotype of Human Adult Dermal Fibroblasts. 33 rd Annual Conference of Indian Rheumatology Association (IRACON), 30 th November–3 rd December, 2017, Lucknow, Uttar Pradesh, India (Presenter).
2017 - 13.
5-HT2/5-HT2B receptor antagonism attenuate 5-HT induced peritoneal fibrosis through non-canonical pathway in patients receiving continuous ambulatory peritoneal dialysis. 48 th Annual Conference of Indian Society of Nephrology (ISNCON), 14 th -17 th December, 2017, New Delhi, India (Presenter).
2017 - 14.
5HT2 and 5HT2B Inhibitors attenuate TGF-β1 mediated Pro-Fibrotic Responses of Human Dermal Fibroblast Cell Line. 43 rd Annual Conference of The Indian Immunology Society (IMMUNOCON), 16 th -18 th February, 2017, Vishakapatnam, Andhra Pradesh, India (Presenter).
2017 - 15.
Kinetics based role of Cystatin-C after intravenous contrast for CT scan in adult ICU population. 47 th Annual Conference of Indian Society of Nephrology (ISNCON), 15 th -18 th December 2016, Mumbai, Maharashtra , India (Presenter).
2016
Patents
- 1.
A Method to Determine a Steroid-Resistant Phenotype in Childhood Idiopathic Nephrotic Syndrome by Utilizing Pharmacogenomic Biomarkers; Patent No. 2021105595, Commonwealth of Australia, IP Australia
2021
